Literature DB >> 26001077

The effect of osteoimmunomodulation on the osteogenic effects of cobalt incorporated β-tricalcium phosphate.

Zetao Chen1, Jones Yuen2, Ross Crawford2, Jiang Chang3, Chengtie Wu4, Yin Xiao5.   

Abstract

Osteoblast lineage cells are direct effectors of osteogenesis and are, therefore, commonly used to evaluate the in vitro osteogenic capacity of bone substitute materials. This method has served its purposes when testing novel bone biomaterials; however, inconsistent results between in vitro and in vivo studies suggest the mechanisms that govern a material's capacity to mediate osteogenesis are not well understood. The emerging field of osteoimmunology and immunomodulation has informed a paradigm shift in our view of bone biomaterials-from one of an inert to an osteoimmunomodulatory material-highlighting the importance of immune cells in materials-mediated osteogenesis. Neglecting the importance of the immune response during this process is a major shortcoming of the current evaluation protocol. In this study we evaluated a potential angiogenic bone substitute material cobalt incorporated with β-tricalcium phosphate (CCP), comparing the traditional "one cell type" approach with a "multiple cell types" approach to assess osteogenesis, the latter including the use of immune cells. We found that CCP extract by itself was sufficient to enhance osteogenic differentiation of bone marrow stem cells (BMSCs), whereas this effect was cancelled out when macrophages were involved. In response to CCP, the macrophage phenotype switched to the M1 extreme, releasing pro-inflammatory cytokines and bone catabolic factors. When the CCP materials were implanted into a rat femur condyle defect model, there was a significant increase of inflammatory markers and bone destruction, coupled with fibrous encapsulation rather than new bone formation. These findings demonstrated that the inclusion of immune cells (macrophages) in the in vitro assessment matched the in vivo tissue response, and that this method provides a more accurate indication of the essential role of immune cells when assessing materials-stimulated osteogenesis in vitro.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone substitute materials; Cobalt; Immunomodulation; Macrophage; Osteogenesis

Mesh:

Substances:

Year:  2015        PMID: 26001077     DOI: 10.1016/j.biomaterials.2015.04.044

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  32 in total

1.  Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy.

Authors:  Settimio Pacelli; Vijayan Manoharan; Anna Desalvo; Nikita Lomis; Kartikeya Singh Jodha; Satya Prakash; Arghya Paul
Journal:  J Mater Chem B       Date:  2015-10-16       Impact factor: 6.331

2.  PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment.

Authors:  Tao Wu; Lei Tan; Ning Cheng; Qi Yan; Yu-Feng Zhang; Chuan-Jun Liu; Bin Shi
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-01-08       Impact factor: 7.328

Review 3.  The material and biological characteristics of osteoinductive calcium phosphate ceramics.

Authors:  Zhurong Tang; Xiangfeng Li; Yanfei Tan; Hongsong Fan; Xingdong Zhang
Journal:  Regen Biomater       Date:  2017-09-08

Review 4.  Macrophages and bone inflammation.

Authors:  Qiaoli Gu; Huilin Yang; Qin Shi
Journal:  J Orthop Translat       Date:  2017-05-23       Impact factor: 5.191

5.  Sustained zinc release in cooperation with CaP scaffold promoted bone regeneration via directing stem cell fate and triggering a pro-healing immune stimuli.

Authors:  Xin Huang; Donghua Huang; Ting Zhu; Xiaohua Yu; Kaicheng Xu; Hengyuan Li; Hao Qu; Zhiyuan Zhou; Kui Cheng; Wenjian Wen; Zhaoming Ye
Journal:  J Nanobiotechnology       Date:  2021-07-12       Impact factor: 10.435

6.  Osteoclastic differentiation and resorption is modulated by bioactive metal ions Co2+, Cu2+ and Cr3+ incorporated into calcium phosphate bone cements.

Authors:  Anne Bernhardt; Martha Schamel; Uwe Gbureck; Michael Gelinsky
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

7.  Impact of bone marrow mesenchymal stem cell immunomodulation on the osteogenic effects of laponite.

Authors:  Tao Li; Zhong Long Liu; Ming Xiao; Ze Zheng Yang; Ming Zheng Peng; Cui Di Li; Xiao Jun Zhou; Jin Wu Wang
Journal:  Stem Cell Res Ther       Date:  2018-04-11       Impact factor: 6.832

8.  Valence State Manipulation of Cerium Oxide Nanoparticles on a Titanium Surface for Modulating Cell Fate and Bone Formation.

Authors:  Jinhua Li; Jin Wen; Bin Li; Wan Li; Wei Qiao; Jie Shen; Weihong Jin; Xinquan Jiang; Kelvin W K Yeung; Paul K Chu
Journal:  Adv Sci (Weinh)       Date:  2017-12-18       Impact factor: 16.806

9.  Nanostructured titanium regulates osseointegration via influencing macrophage polarization in the osteogenic environment.

Authors:  Jinjin Wang; Fanhui Meng; Wen Song; Jingyi Jin; Qianli Ma; Dongdong Fei; Liang Fang; Lihua Chen; Qintao Wang; Yumei Zhang
Journal:  Int J Nanomedicine       Date:  2018-07-10

Review 10.  Smart Cargo Delivery System based on Mesoporous Nanoparticles for Bone Disease Diagnosis and Treatment.

Authors:  Panpan Pan; Qin Yue; Juan Li; Meiqi Gao; Xuanyu Yang; Yuan Ren; Xiaowei Cheng; Penglei Cui; Yonghui Deng
Journal:  Adv Sci (Weinh)       Date:  2021-03-16       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.